L. Katz, Director Emeritus Glaucoma Service Wills Eye Hospital, Professor of Ophthalmology Thomas Jefferson University
Dr. L Jay Katz, M.D. is a current Attending Surgeon at Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University located in Philadelphia, PA. He went to Case Western Reserve University where he graduated Summa Cum Laude before going on to Yale University Medical School where he received his M.D. After this he had an internship at the University of Virginia in Internal Medicine, then participated in a residency in ophthalmology at Yale University, leading to his completion of a fellowship in glaucoma at Wills Eye Hospital.
Dr. Katz, M.D. has received distinctive awards in his field. He is the recipient of the American Academy of Ophthalmology Honor Award as well as the Senior Achievement Award given to notable specialists who contribute top research in the field of vision care. In addition, he is an Honored Life Member of the Philadelphia Ophthalmic Club and received the Silver Tray Award from Wills Eye Hospital which is awarded for outstanding service to the establishment by exceptional specialists. Wills Eye also named him as an honoree at the 50th anniversary of the glaucoma service. Dr Katz was named distinguished alumnus of the Yale University ophthalmology department. He has served as past president of the Ophthalmic Club, the Metro chapter of the American College of Surgeons, the Wills Eye Hospital faculty staff, and also was the treasurer for 2 terms for the American Glaucoma Society. At Wills Eye Hospital Dr Katz served as the Director for over 10 years. Recently he has been named the chief medical officer of Glaukos a glaucoma medical device company. He is an editorial board member for Survey of Ophthalmology, Journal of Glaucoma, Graefes Clinical and Experimental Journal of Ophthalmology, Medscape and the Open Journal of Ophthalmology. Dr Katz has authored over 200 scientific articles and book chapters and been a recipient of numerous research grants including those from the National Eye Institute, the Centers for Disease Control, the Glaucoma Research Foundation and private industry.